Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14

DLBCL is an aggressive lymphoma treated with R-CHOP. Recently, attempts have been made to improve the outcome by increasing both dose-density and intensity but there have been no benefits in terms of survival. When treating malignancies RDI is important to consider but there is little published info...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez, Antonio, Bento, Leyre, Bautista-Gili, Antonia Maria, Garcia, Francesc, Martinez-Serra, Jordi, Sanchez, Blanca, Martorell, Clara, Gines, Jordi, Garcia, Lucia, Gimeno, Eva, Ferraro, Mariana, Del Campo, Raquel, Bargay, Joan, Perez, Albert, Vercher, Javier, Scaff, Miguel, Pacheco, Ana, Ballester, Carmen, Garcia, Florencia, Ramos, Rafael, Salar, Antonio, Besalduch, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409365/
https://www.ncbi.nlm.nih.gov/pubmed/25909361
http://dx.doi.org/10.1371/journal.pone.0123978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409365/
https://www.ncbi.nlm.nih.gov/pubmed/25909361
http://dx.doi.org/10.1371/journal.pone.0123978

Ejemplares similares